Interleukin-15 (dys)regulation of lymphoid homeostasis: Implications for therapy of autoimmunity and cancer.


Journal

The Journal of experimental medicine
ISSN: 1540-9538
Titre abrégé: J Exp Med
Pays: United States
ID NLM: 2985109R

Informations de publication

Date de publication:
06 01 2020
Historique:
received: 13 06 2019
revised: 30 08 2019
accepted: 30 10 2019
entrez: 11 12 2019
pubmed: 11 12 2019
medline: 14 7 2020
Statut: ppublish

Résumé

IL-15, a pleiotropic cytokine, stimulates generation of NK, NK-T, γδ, ILC1, and memory CD8 T cells. IL-15 disorders play pathogenetic roles in organ-specific autoimmune diseases including celiac disease. Diverse approaches are developed to block IL-15 action. IL-15 administered to patients with malignancy yielded dramatic increases in NK numbers and modest increases in CD8 T cells. Due to immunological checkpoints, to achieve major cancer therapeutic efficacy, IL-15 will be used in combination therapy, and combination trials with checkpoint inhibitors, with anti-CD40 to yield tumor-specific CD8 T cells, and with anticancer monoclonal antibodies to increase ADCC and antitumor efficacy, have been initiated.

Identifiants

pubmed: 31821442
pii: 132622
doi: 10.1084/jem.20191062
pmc: PMC7037239
pii:
doi:

Substances chimiques

Antibodies, Monoclonal 0
Interleukin-15 0

Types de publication

Journal Article Research Support, N.I.H., Intramural Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Références

J Immunol. 2014 Jun 15;192(12):5451-8
pubmed: 24907378
Blood. 1998 Jul 1;92(1):252-8
pubmed: 9639524
Exp Hematol. 2011 Nov;39(11):1064-71
pubmed: 21864486
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15849-54
pubmed: 19805228
Breast Cancer Res Treat. 2012 Dec;136(3):659-71
pubmed: 23065032
Immunol Cell Biol. 2017 Apr;95(4):347-355
pubmed: 28138156
Biomed Pharmacother. 2019 Apr;112:108677
pubmed: 30798123
Science. 1994 May 13;264(5161):965-8
pubmed: 8178155
J Exp Med. 2002 Jun 17;195(12):1541-8
pubmed: 12070282
Cancer Immunol Res. 2015 Mar;3(3):219-27
pubmed: 25736261
Lancet Oncol. 2018 May;19(5):694-704
pubmed: 29628312
Clin Cancer Res. 2010 Dec 15;16(24):6019-28
pubmed: 20924130
Blood. 2011 May 5;117(18):4787-95
pubmed: 21385847
Proc Natl Acad Sci U S A. 2012 Apr 17;109(16):6187-92
pubmed: 22474386
Cancer Res. 2015 Dec 15;75(24):5187-5193
pubmed: 26627006
J Clin Invest. 2003 Nov;112(10):1571-80
pubmed: 14617758
Nature. 1998 Jun 4;393(6684):478-80
pubmed: 9624004
Oncoimmunology. 2017 Nov 13;7(2):e1393597
pubmed: 29308327
J Immunol. 2006 Jul 1;177(1):450-8
pubmed: 16785542
Immunity. 2002 Nov;17(5):537-47
pubmed: 12433361
Cytokine. 2012 Sep;59(3):479-90
pubmed: 22795955
Nat Med. 2014 Sep;20(9):1043-9
pubmed: 25129481
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
Blood Cells Mol Dis. 2001 Jan-Feb;27(1):223-30
pubmed: 11358383
Immunity. 2014 Aug 21;41(2):169-71
pubmed: 25148017
J Clin Invest. 1997 Mar 1;99(5):937-43
pubmed: 9062351
Dig Dis. 2015;33(2):122-30
pubmed: 25925912
Nat Commun. 2017 Mar 31;8:14601
pubmed: 28361874
Cancer Immunol Res. 2019 Jul;7(7):1162-1174
pubmed: 31088844
Cytokine Growth Factor Rev. 2011 Apr;22(2):99-108
pubmed: 21531164
Nat Med. 2003 Mar;9(3):279-86
pubmed: 12579196
J Biol Chem. 2008 Feb 15;283(7):4189-99
pubmed: 18055460
Int Rev Immunol. 1998;16(3-4):205-26
pubmed: 9505189
Eur J Immunol. 2009 Aug;39(8):2088-94
pubmed: 19637200
Sci Transl Med. 2018 Jul 18;10(450):
pubmed: 30021889
Immunity. 2018 Apr 17;48(4):760-772.e4
pubmed: 29625893
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):401-6
pubmed: 16387851
Immunol Rev. 2010 Jul;236:68-82
pubmed: 20636809
J Transl Med. 2019 Jan 17;17(1):29
pubmed: 30654801
J Biol Chem. 2015 Sep 11;290(37):22338-51
pubmed: 26183780
Pharm Res. 2001 Apr;18(4):548-50
pubmed: 11451045
Immunity. 2001 Feb;14(2):105-10
pubmed: 11239443
Cell Immunol. 1997 Jul 10;179(1):66-73
pubmed: 9259773
J Exp Med. 2007 Apr 16;204(4):951-61
pubmed: 17420265
Nature. 1998 Jun 4;393(6684):474-8
pubmed: 9624003
J Biol Chem. 2016 Nov 11;291(46):23869-23881
pubmed: 27650494
J Immunol. 2016 Jul 1;197(1):168-78
pubmed: 27217584
J Exp Med. 2013 Sep 23;210(10):2105-17
pubmed: 24019554
J Leukoc Biol. 1996 Apr;59(4):476-80
pubmed: 8613692
Int J Immunogenet. 2018 Jul 16;:
pubmed: 30009514
J Immunol. 2010 Jul 15;185(2):917-28
pubmed: 20543098
Cytokine Growth Factor Rev. 2002 Apr;13(2):169-83
pubmed: 11900992
Leukemia. 2019 May;33(5):1243-1255
pubmed: 30353031
Clin Cancer Res. 2014 Apr 15;20(8):2044-50
pubmed: 24737791
J Immunol. 2003 Sep 1;171(5):2435-45
pubmed: 12928391
Cancer Immunol Res. 2017 Oct;5(10):929-938
pubmed: 28842470
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10915-E10924
pubmed: 30373815
Blood. 2011 Dec 22;118(26):6845-8
pubmed: 22067383
Nat Rev Immunol. 2006 Aug;6(8):595-601
pubmed: 16868550
Blood. 2011 Apr 14;117(15):4032-40
pubmed: 21304101
Blood. 2001 Jan 1;97(1):14-32
pubmed: 11133738
Immunity. 1996 Apr;4(4):329-36
pubmed: 8612127
Front Immunol. 2017 Apr 13;8:438
pubmed: 28450869
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415897
Immunity. 2015 May 19;42(5):826-38
pubmed: 25992859
Cancer Cell. 2012 Nov 13;22(5):645-55
pubmed: 23153537
Clin Cancer Res. 2019 Aug 15;25(16):4945-4954
pubmed: 31142503
J Immunol. 2009 Dec 15;183(12):8268-79
pubmed: 20007590
J Innate Immun. 2015;7(6):563-71
pubmed: 25924651
Immunol Cell Biol. 2014 Mar;92(3):210-3
pubmed: 24492800
Mol Ther. 2016 Aug;24(7):1312-22
pubmed: 27157665
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4940-4
pubmed: 8197161
Annu Rev Immunol. 2004;22:503-29
pubmed: 15032587
Proc Natl Acad Sci U S A. 2008 Oct 21;105(42):16308-13
pubmed: 18852469
Cold Spring Harb Perspect Biol. 2018 Sep 4;10(9):
pubmed: 29038115
Immunity. 2015 Aug 18;43(2):240-50
pubmed: 26231116
J Immunol. 2008 Feb 15;180(4):2099-106
pubmed: 18250415
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13534-9
pubmed: 23904478
MAbs. 2014 Jul-Aug;6(4):1026-37
pubmed: 25072059
Blood. 2011 Feb 10;117(6):1938-46
pubmed: 21106989
Nat Med. 2006 Mar;12(3):335-41
pubmed: 16474399
Arthritis Rheum. 1999 Jul;42(7):1508-16
pubmed: 10403280
J Clin Oncol. 2019 Mar 10;37(8):677-687
pubmed: 30657736
Nat Med. 1996 Feb;2(2):175-82
pubmed: 8574962
Adv Immunol. 2005;86:209-39
pubmed: 15705423
Annu Rev Immunol. 2006;24:657-79
pubmed: 16551262
Cancer Cell. 2016 Jun 13;29(6):820-831
pubmed: 27265505
Arthritis Rheum. 2005 Sep;52(9):2686-92
pubmed: 16142748
Immunity. 2016 Sep 20;45(3):610-625
pubmed: 27612641
J Neuroimmunol. 2008 Mar;195(1-2):135-9
pubmed: 18378324
Eur Cytokine Netw. 2002 Jul-Sep;13(3):364-8
pubmed: 12231481
Blood. 2012 Dec 6;120(24):4751-60
pubmed: 22983442
Clin Cancer Res. 2018 Apr 1;24(7):1525-1535
pubmed: 29203590
Immunol Lett. 2017 Oct;190:159-168
pubmed: 28823521
Nat Immunol. 2016 Jul;17(7):816-24
pubmed: 27213690
Nat Rev Immunol. 2009 Jul;9(7):480-90
pubmed: 19543225
Science. 2006 Mar 31;311(5769):1924-7
pubmed: 16484453
J Immunol. 1998 Jun 15;160(12):5742-8
pubmed: 9637483
Blood. 2008 May 15;111(10):5163-72
pubmed: 18339896
J Immunol. 2012 Jun 15;188(12):6156-64
pubmed: 22593619
Science. 2011 Aug 19;333(6045):1030-4
pubmed: 21852502
J Immunother Cancer. 2019 Mar 21;7(1):82
pubmed: 30898149
Postepy Hig Med Dosw (Online). 2017 Jan 10;71(0):5-19
pubmed: 28181907
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1969-74
pubmed: 14762166
Trends Pharmacol Sci. 2012 Jan;33(1):35-41
pubmed: 22032984
Acta Neurol Scand. 2012 Feb;125(2):77-82
pubmed: 21615353
Cytokine. 2018 Aug;108:213-224
pubmed: 29402721
Pathol Biol (Paris). 2003 Mar;51(2):64-6
pubmed: 12801802
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4935-9
pubmed: 8197160
Nat Rev Immunol. 2015 Dec;15(12):771-83
pubmed: 26567920
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11445-50
pubmed: 11016962
Immunity. 2007 Apr;26(4):503-17
pubmed: 17398124
Cold Spring Harb Perspect Biol. 2018 Dec 3;10(12):
pubmed: 29101107
Cytokine Growth Factor Rev. 2016 Oct;31:49-59
pubmed: 27325459
J Immunol. 2009 Sep 15;183(6):3598-607
pubmed: 19710453
Blood. 2018 Jun 7;131(23):2515-2527
pubmed: 29463563
Methods Mol Biol. 2011;707:3-17
pubmed: 21287325
Trends Mol Med. 2003 Dec;9(12):517-21
pubmed: 14659465
Cell Rep. 2013 Sep 26;4(6):1235-49
pubmed: 24055061
J Immunol. 2004 Nov 1;173(9):5818-26
pubmed: 15494535
Proc Natl Acad Sci U S A. 2015 Oct 6;112(40):12480-5
pubmed: 26396258
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2897-902
pubmed: 8610139
Expert Rev Clin Immunol. 2014 Dec;10(12):1689-701
pubmed: 25359408
Nat Immunol. 2013 Dec;14(12):1294-301
pubmed: 24162776
Sci Transl Med. 2016 Sep 21;8(357):357ra123
pubmed: 27655849
Proc Natl Acad Sci U S A. 2009 May 5;106(18):7513-8
pubmed: 19383782
J Biol Chem. 2013 Jun 21;288(25):18093-103
pubmed: 23649624
Mucosal Immunol. 2018 Sep;11(5):1281-1289
pubmed: 29674648
Mol Immunol. 2002 Dec;39(9):537-44
pubmed: 12431387
J Exp Med. 2009 Jan 16;206(1):25-34
pubmed: 19103877
Immunol Rev. 2014 Jul;260(1):221-34
pubmed: 24942692
Rheumatology (Oxford). 2001 Aug;40(8):876-81
pubmed: 11511756
Blood. 2012 Jan 5;119(1):137-43
pubmed: 22049515
Immunity. 2013 Apr 18;38(4):769-81
pubmed: 23453631
Nat Rev Immunol. 2003 Apr;3(4):269-79
pubmed: 12669018
Blood. 2005 Jan 15;105(2):721-7
pubmed: 15367431
Annu Rev Immunol. 1999;17:221-53
pubmed: 10358758
Blood. 2003 Dec 1;102(12):4115-22
pubmed: 12907450
Clin Cancer Res. 2018 Nov 15;24(22):5552-5561
pubmed: 30045932
Blood. 2012 Jul 5;120(1):e1-8
pubmed: 22496150
Int Immunol. 2008 Jul;20(7):937-47
pubmed: 18495626
Vaccine. 2004 Sep 3;22(25-26):3510-21
pubmed: 15308379
Cell Immunol. 1995 Oct 15;165(2):289-93
pubmed: 7553894
Proc Natl Acad Sci U S A. 2003 Apr 15;100(8):4724-9
pubmed: 12671073
Blood. 2013 Jan 17;121(3):476-84
pubmed: 23212516
Nature. 1998 Jun 4;393(6684):480-3
pubmed: 9624005
Sci Rep. 2016 May 11;6:25822
pubmed: 27166125
Clin Immunol. 2009 Aug;132(2):153-65
pubmed: 19428306
JCI Insight. 2016 Sep 22;1(15):e89790
pubmed: 27699253
Mol Cell. 2009 Dec 11;36(5):754-67
pubmed: 20005840
Mol Ther. 2018 Oct 3;26(10):2476-2486
pubmed: 30064894
Cancer Discov. 2016 Sep;6(9):986-1005
pubmed: 27422033
Gastroenterology. 2014 Apr;146(4):1017-27
pubmed: 24361466
Blood Rev. 2006 May;20(3):123-37
pubmed: 16364519
Front Immunol. 2018 Jul 11;9:1603
pubmed: 30050538
Immunity. 2014 Aug 21;41(2):230-43
pubmed: 25148024

Auteurs

Thomas A Waldmann (TA)

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Milos D Miljkovic (MD)

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Kevin C Conlon (KC)

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH